#Pharmacology #ClinicalPharmacology #DrugDiscovery #PharmaResearch #ObesityTreatment #HealthcareInnovation #DrugSafety One key point: GLP-1 agonists act on both metabolic pathways and appetite regulation, making them highly effective
Glutathione deficiency: Signs, symptoms, causes, and consequences Glutathione deficiency: Signs, symptoms, causes, and consequences A glutathione deficiency can manifest as increased fatigue, weakened immune system, and higher susceptibility to infections and chronic diseases
SCFAs activate receptors (FFAR2, FFAR3 / GPR41, GPR43) on L-cells GLP-1 release
We found that glutathione (GSH) levels were associated with MTX resistance in both treated and untreated cells, suggesting a new constitutive metabolic-based mechanism of resistance to the drug